Actively Recruiting
Evaluating Bexagliflozin Versus Placebo for Reducing Sleep Apnea Severity in Overweight and Obese Adults with Moderate to Severe OSA
Led by Yale University · Updated on 2026-08-27
164
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether bexagliflozin, a drug taken once daily, can reduce the severity of obstructive sleep apnea OSA in adults who are overweight or obese with moderate to severe OSA. The study aims to understand if this treatment can improve anatomical and physiological traits related to sleep apnea, as well as overall clinical measures and sleep deficiency. The trial is a randomized, placebo-controlled study conducted at two centers involving adults with a body mass index BMI between 25 and 40 kgm2. Participants will be randomly assigned to receive either bexagliflozin 20 mg once daily or a matching placebo, in addition to their routine clinical care, for six months. During the study, researchers will measure changes in fat distribution using MRI, airway structure and function, neck circumference, and various sleep apnea severity indicators. Assessments will occur at the beginning and end of the study to evaluate the impact of the drug on OSA and related physiological traits. Throughout the six months, participants will undergo comprehensive evaluations including full ambulatory polysomnography, MRI imaging, blood tests for biomarkers, and questionnaires assessing sleep quality and daytime sleepiness. Researchers will monitor changes in apnea hypopnea index AHI, oxygen levels, sleep arousal, body measurements, and blood pressure. This thorough monitoring will help determine the effects of bexagliflozin on sleep apnea severity and related health factors.
CONDITIONS
Brief Title
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
Research Team
H
Henry K Yaggi, M.D.
I
Ian J Neeland, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here